Jeffrey Robert Ajer - Mar 15, 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
EVP, Chief Commercial Officer
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Stock symbol
BMRN
Transactions as of
Mar 15, 2022
Transactions value $
-$762,764
Form type
4
Date filed
3/17/2022, 09:11 PM
Previous filing
Mar 10, 2022
Next filing
Mar 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $0 +11.9K +18.31% $0.00 77.2K Mar 15, 2022 Direct F1
transaction BMRN Common Stock Tax liability -$659K -8.42K -10.91% $78.27 68.7K Mar 15, 2022 Direct
transaction BMRN Common Stock Tax liability -$104K -1.29K -1.87% $80.72 67.5K Mar 16, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Award $0 +28.7K $0.00 28.7K Mar 15, 2022 Common Stock 28.7K $78.27 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted on March 15, 2022. Price not applicable.
F2 Option grant vests 12/48th on March 15, 2023 and 1/48th on the 15th day of each month thereafter.